FALCONE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 12.849
AS - Asia 6.777
EU - Europa 3.254
SA - Sud America 1.582
AF - Africa 273
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 10
Totale 24.768
Nazione #
US - Stati Uniti d'America 12.505
SG - Singapore 2.428
HK - Hong Kong 1.556
CN - Cina 1.400
BR - Brasile 1.303
IT - Italia 980
BG - Bulgaria 517
VN - Vietnam 442
SE - Svezia 433
DE - Germania 339
GB - Regno Unito 272
RU - Federazione Russa 222
CA - Canada 221
IN - India 202
TR - Turchia 182
BD - Bangladesh 94
AR - Argentina 84
FI - Finlandia 79
JP - Giappone 72
CI - Costa d'Avorio 68
AT - Austria 63
FR - Francia 62
IQ - Iraq 59
MX - Messico 55
KR - Corea 51
ZA - Sudafrica 49
VE - Venezuela 46
SA - Arabia Saudita 44
NL - Olanda 43
PL - Polonia 40
EC - Ecuador 37
CZ - Repubblica Ceca 32
ID - Indonesia 32
PK - Pakistan 32
CO - Colombia 31
ES - Italia 30
SN - Senegal 29
UA - Ucraina 29
MA - Marocco 28
KE - Kenya 22
UZ - Uzbekistan 22
PY - Paraguay 20
JO - Giordania 19
UY - Uruguay 19
AE - Emirati Arabi Uniti 18
PE - Perù 18
AU - Australia 17
TN - Tunisia 17
EG - Egitto 16
IE - Irlanda 15
NG - Nigeria 15
CH - Svizzera 13
NP - Nepal 13
PH - Filippine 13
CL - Cile 12
HU - Ungheria 11
JM - Giamaica 11
TT - Trinidad e Tobago 11
AZ - Azerbaigian 10
AL - Albania 9
DZ - Algeria 9
IL - Israele 9
LT - Lituania 9
BE - Belgio 8
IS - Islanda 8
PS - Palestinian Territory 8
BB - Barbados 7
BO - Bolivia 7
EU - Europa 7
GE - Georgia 7
HN - Honduras 7
KZ - Kazakistan 7
OM - Oman 7
CR - Costa Rica 6
MY - Malesia 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
AO - Angola 5
DO - Repubblica Dominicana 5
GR - Grecia 5
NZ - Nuova Zelanda 5
PA - Panama 5
BH - Bahrain 4
GT - Guatemala 4
IR - Iran 4
KW - Kuwait 4
MD - Moldavia 4
SV - El Salvador 4
BA - Bosnia-Erzegovina 3
GY - Guiana 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
LY - Libia 3
RO - Romania 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
Totale 24.722
Città #
Hong Kong 1.552
Dallas 1.512
Ashburn 1.408
Singapore 1.368
Fairfield 1.209
Santa Clara 903
Chandler 663
Shanghai 599
Woodbridge 557
Boulder 524
Sofia 516
Seattle 513
Houston 467
Wilmington 414
Cambridge 408
New York 367
Boardman 295
Beijing 249
Los Angeles 234
Princeton 233
Milan 225
Lawrence 217
Des Moines 163
Ann Arbor 156
Medford 154
Istanbul 137
Ottawa 134
Munich 123
Florence 116
São Paulo 107
Ho Chi Minh City 106
London 100
Redondo Beach 95
San Diego 87
Frankfurt am Main 76
Pisa 75
Buffalo 70
Abidjan 68
Dong Ket 62
Hanoi 62
Rome 56
Serra 54
Tokyo 54
Ogden 53
Bremen 51
Rio de Janeiro 48
Vienna 48
Chicago 47
Seoul 47
Hefei 46
Nanjing 46
Columbus 42
Turku 42
Nuremberg 39
Belo Horizonte 36
Hyderabad 36
The Dalles 35
Council Bluffs 34
Warsaw 33
Brasília 31
Dakar 29
Stockholm 27
Pune 26
San Jose 26
Brno 25
Hebei 25
Redwood City 24
Curitiba 23
Johannesburg 23
Fuzhou 22
Nanchang 22
Baghdad 21
Dhaka 21
Toronto 21
Brooklyn 20
Tianjin 20
Changsha 19
Nairobi 19
Phoenix 19
Porto Alegre 19
Tashkent 19
Atlanta 18
Dearborn 18
Denver 18
Falls Church 18
Lappeenranta 18
Amman 17
Düsseldorf 17
San Francisco 17
Ankara 16
Kent 16
Montreal 16
Riyadh 16
Shenyang 16
Vicopisano 16
Helsinki 15
Norwalk 15
Lima 14
Lucca 14
Montevideo 14
Totale 17.981
Nome #
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 209
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 201
Clinical features and outcomes of infections caused by metallo-β-lactamases producing Enterobacterales: a 3-year prospective study from an endemic area 199
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 199
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 188
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019 170
Pharyngeal and cutaneous diphtheria: a tail of a refugee 165
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 165
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 165
Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update 163
A rare case of mycobacterial pseudoaneurysm of the superficial femoral artery 162
What is the clinical significance of 'heteroresistance' in nonfermenting Gram-negative strains? 160
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 159
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 159
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 158
Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization 153
A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy 150
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 147
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 146
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience 143
Therapeutic drug monitoring of antibiotics for methicillin-resistant Staphylococcus aureus infections: an updated narrative review for clinicians 142
Predictors of mortality in solid-organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia 142
Physical, Mental and Sexual Health Among Transgender Women. A comparative Study Among Operated Transgender and Cisgender Women in a National Tertiary Referral Network 140
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy 140
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 139
Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy 133
Healthcare-associated pneumonia and multidrug-resistant bacteria: Do we have a convincing answer? 131
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study 131
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 130
Clinical experience of anidulafungin for the treatment of patients with documented candidemia 130
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 130
Candidaemia after heart valve replacement surgery: recurrence as prosthetic valve endocarditis is an expected over one-year complication 128
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 128
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link? 126
Healthcare-associated pneumonia: a never-ending story 126
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 126
High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis 125
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis 124
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 123
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 122
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 121
Is NOX2 Upregulation Implicated in Myocardial Injury in Patients with Pneumonia? 121
Surveillance and management of multidrug-resistant microorganisms 121
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 120
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis 120
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections 120
Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia 120
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 118
Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study 118
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: a prospective cohort study 117
Candidal thrombophlebitis of central veins: case report and review 117
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 116
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 116
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia 115
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 115
Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid 115
Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience 114
Cirrhotic patients are at risk for health care-associated bacterial infections 114
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae 114
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 114
Performance status and in-hospital mortality of elderly patients with community acquired pneumonia 114
Platelet activation is associated with myocardial infarction in patients with pneumonia 113
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 113
Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events 112
Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for COVID-19 pneumonia: An exploratory pilot study 112
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis 111
Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: new insights and evidence from the literature 111
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study 111
Pneumonia in frail older patients: An up to date 110
In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes 110
Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? 110
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 110
Diabetes and acute bacterial skin and skin structure infections 109
Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey 109
Early identification of severe community-onset pneumonia in "frail elderly patient" 108
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection 108
Identification and management of invasive mycoses in internal medicine: a road-map for physicians 107
Invasive aspergillosis in patients with liver disease 107
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy 107
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 106
Low-grade endotoxemia and clotting activation in the early phase of pneumonia 105
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 105
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort 105
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures 105
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 105
CAP and HCAP are different? An unresolved question 104
Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification 104
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 103
Role of aspirin in patients with septic shock: a complex and intriguing relationship 103
Simplified Equations Using Two Concentrations To Calculate Area under the Curve for Antimicrobials with Concentration-Dependent Pharmacodynamics: Daptomycin as a Motivating Example 103
Health care associated pneumonia: a new clinical entity 103
The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis 102
Native-Valve Aspergillus Endocarditis: Case Report and Literature Review 102
Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia 102
Surgical debridement with muscle flap transposition and systemic teicoplanin therapy for infected hip arthroplasty 102
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae 102
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 102
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 102
Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae 101
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 101
Totale 12.582
Categoria #
all - tutte 84.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021860 0 0 0 0 0 42 116 78 160 90 125 249
2021/20222.140 70 122 69 98 384 313 127 129 101 48 151 528
2022/20232.319 298 197 167 214 267 345 35 193 373 10 175 45
2023/20241.768 119 142 158 95 242 370 150 50 31 16 115 280
2024/20258.044 59 307 68 483 592 846 637 370 768 961 729 2.224
2025/20265.725 519 932 1.432 1.283 915 644 0 0 0 0 0 0
Totale 25.253